Works matching DE "POLYGLUTAMINE"


Results: 444
    1
    2
    3

    Modification of Huntington's disease by short tandem repeats.

    Published in:
    Brain Communications, 2024, v. 6, n. 2, p. 1, doi. 10.1093/braincomms/fcae016
    By:
    • Hong, Eun Pyo;
    • Ramos, Eliana Marisa;
    • Aziz, N Ahmad;
    • Massey, Thomas H;
    • McAllister, Branduff;
    • Lobanov, Sergey;
    • Jones, Lesley;
    • Holmans, Peter;
    • Kwak, Seung;
    • Orth, Michael;
    • Ciosi, Marc;
    • Lomeikaite, Vilija;
    • Monckton, Darren G;
    • Long, Jeffrey D;
    • Lucente, Diane;
    • Wheeler, Vanessa C;
    • Gillis, Tammy;
    • MacDonald, Marcy E;
    • Sequeiros, Jorge;
    • Gusella, James F
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Polyglutamine (polyQ) disorders.

    Published in:
    Nucleus (1949-1034), 2012, v. 3, n. 5, p. 1, doi. 10.4161/nucl.21481
    By:
    • Cohen-Carmon, Dorit;
    • Meshorer, Eran
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.

    Published in:
    Acta Neuropathologica, 2016, v. 132, n. 1, p. 127, doi. 10.1007/s00401-016-1550-4
    By:
    • Rocchi, Anna;
    • Milioto, Carmelo;
    • Parodi, Sara;
    • Armirotti, Andrea;
    • Borgia, Doriana;
    • Pellegrini, Matteo;
    • Urciuolo, Anna;
    • Molon, Sibilla;
    • Morbidoni, Valeria;
    • Marabita, Manuela;
    • Romanello, Vanina;
    • Gatto, Pamela;
    • Blaauw, Bert;
    • Bonaldo, Paolo;
    • Sambataro, Fabio;
    • Robins, Diane;
    • Lieberman, Andrew;
    • Sorarù, Gianni;
    • Vergani, Lodovica;
    • Sandri, Marco
    Publication type:
    Article
    35
    36
    37
    38
    39

    The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85656-x
    By:
    • Le Cann, Kim;
    • Foerster, Alec;
    • Rösseler, Corinna;
    • Erickson, Andelain;
    • Hautvast, Petra;
    • Giesselmann, Sebastian;
    • Pensold, Daniel;
    • Kurth, Ingo;
    • Rothermel, Markus;
    • Mattis, Virginia B.;
    • Zimmer-Bensch, Geraldine;
    • von Hörsten, Stephan;
    • Denecke, Bernd;
    • Clarner, Tim;
    • Meents, Jannis;
    • Lampert, Angelika
    Publication type:
    Article
    40
    41
    42

    Dysregulation of zebrin-II cell subtypes in the cerebellum is a shared feature across polyglutamine ataxia mouse models and patients.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 772, p. 1, doi. 10.1126/scitranslmed.adn5449
    By:
    • Bartelt, Luke C.;
    • Switonski, Pawel M.;
    • Adamek, Grażyna;
    • Longo, Fabiana;
    • Carvalho, Juliana;
    • Duvick, Lisa A.;
    • Jarrah, Sabrina I.;
    • McLoughlin, Hayley S.;
    • Scoles, Daniel R.;
    • Pulst, Stefan M.;
    • Orr, Harry T.;
    • Hull, Court;
    • Lowe, Craig B.;
    • La Spada, Albert R.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50